That is interesting, I'm learning a lot from this
Post# of 148300
I've often wondered if withing the 800+ trial participants in the HIV trials we have learned about Leronlimab's MOA in issues other than just HIV. Some of these patients have NASH, MS, got the flu etc.. I wonder if the side effect of Leronlimab has uncovered details of some of these diseases we did not know before and/or Leronlimab's influence on them.